Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

ClinicalTrials.gov ID: NCT00492206

Public ClinicalTrials.gov record NCT00492206. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 9:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Cetuximab in Combination With External Beam Radiation Followed By Consolidation Chemotherapy for Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open label, phase II study in which cetuximab with concurrent thoracic radiotherapy followed by consolidation chemotherapy with paclitaxel/carboplatin/cetuximab will be administered to subjects with locally advanced NSCLC.

Study identification

NCT ID
NCT00492206
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Pittsburgh
Other
Enrollment
40 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Jan 31, 2012
Completion
Jan 31, 2012
Last update posted
Jan 31, 2017

2006 – 2012

United States locations

U.S. sites
31
U.S. states
5
U.S. cities
20
Facility City State ZIP Site status
Sylvester Comprehensive Cancer Center, University of Miami Miami Florida 33136 —
Emory Winship Cancer Institute Atlanta Georgia 30322 —
Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore Maryland 21231 —
UPMC Cancer Center -Teramana Cancer Center Steubenville Ohio 43952 —
UPMC Cancer Center -Beaver Beaver Pennsylvania 15009 —
UPMC Cancer Center - Clairton Clairton Pennsylvania 15025 —
UPMC Cancer Center - Oakbrook Commons Greensburg Pennsylvania 15601 —
UPMC Cancer Center -Arnold Palmer Pavilion Greensburg Pennsylvania 15601 —
Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
UPMC Cancer Center -Indiana Indiana Pennsylvania 15701 —
UPMC Cancer Center -John P. Murtha Pavilion Johnstown Pennsylvania 15901 —
UPMC Cancer Center -McKeesport McKeesport Pennsylvania 15132 —
UPMC Cancer Center -Haymaker Rd. Monroeville Pennsylvania 15146 —
UPMC Cancer Center -Mosside Blvd. Monroeville Pennsylvania 15146 —
UPMC Cancer Center -Sewickley Medical Center Moon Township Pennsylvania 15108 —
UPMC Cancer Center -Mt. Pleasant Mount Pleasant Pennsylvania 15666 —
UPMC Cancer Center -Jameson New Castle Pennsylvania 16105 —
UPMC Cancer Center -New Castle New Castle Pennsylvania 16105 —
UPMC Presbyterian -Radiation Oncology Pittsburgh Pennsylvania 15213 —
UPMC Cancer Center -Delafield Rd. Pittsburgh Pennsylvania 15215 —
UPMC Cancer Center -St. Margaret Pittsburgh Pennsylvania 15215 —
Universtity of Pittsburgh Cancer Institute -Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
UPMC Cancer Center -UPMC Shadyside Pittsburgh Pennsylvania 15232 —
UPMC Cancer Center -Passavant Pittsburgh Pennsylvania 15237 —
UPMC Cancer Center -Drake Pittsburgh Pennsylvania 15241 —
UPMC Cancer Center -St. Clair Pittsburgh Pennsylvania 15243 —
UPMC Cancer Center -UPMC Northwest Seneca Pennsylvania 16346 —
UPMC Cancer Center -Robert Eberly Pavilion Uniontown Pennsylvania 15401 —
UPMC Cancer Center -Uniontown Uniontown Pennsylvania 15401 —
UPMC Cancer Center -Washington Washington Pennsylvania 15301 —
UPMC Cancer Center -Wexford Wexford Pennsylvania 15090 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00492206, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2017 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00492206 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →